Axitinib 1 mg, 5 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1 mg, 5 mg
Reference Brands: Inlyta®(EU & US)
Category: Oncology Cancer Care
Axitinib 1 mg and 5 mg Tablets are used in oncology for the treatment of metastatic renal cell carcinoma (RCC). Available under the brand name Inlyta®, Axitinib is a tyrosine kinase inhibitor that targets VEGF receptors to inhibit tumor growth. It is used as a second-line therapy after the failure of prior treatments like sunitinib or pazopanib. Available in oral tablet form, it is typically taken twice daily.
Product Description: Axitinib 1 mg and 5 mg Tablets are a key treatment for metastatic renal cell carcinoma (RCC), primarily used as a second-line therapy for patients who have failed prior treatments like sunitinib or pazopanib. As a tyrosine kinase inhibitor, Axitinib targets the VEGF receptors involved in tumor angiogenesis, thus slowing the growth of cancer cells. Approved under the brand name Inlyta® in both the U.S. and EU, Axitinib is essential in oncology B2B portfolios for advanced RCC treatment. It is typically administered twice daily in oral tablet form at doses of 1 mg or 5 mg.
Axitinib — third party manufacturing & bulk supply
Axitinib 1 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Axitinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Axitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Axitinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
